Mitsubishi Tanabe Pharma Clinical Trial Information Site

List of Summaries of Clinical Trial Information

The clinical trial information and results posted on ClinicalTrials.gov or CTIS of public registries are available after performing a search in the following.

The studies listed in the “Summary Results” and “Summary Results in Plain Language “ in the “List of Summaries of Clinical Trial Information” are clinical trials of a product which the first indication was approved in or after January 2018 in patients who applied for approval of marketing approved in all regions of the US, Europe, and Japan where approval is sought.
However, the results will not be disclosed if MTPC determines that there is a risk that the clinical trial participants could be identified. The results may not be disclosed in the following conditions:

  • ・A third party, such as a company involved in joint development, has not agreed to disclosure.
  • ・Disclosure may interfere with publication in medical journals.
  • ・Disclosure may interfere with the protection of intellectual property rights.

Search Results

Disease
Area
Development
Code
(Generic Name)
Clinical Trial No. Medical Indication
or
Disease
Phase Status of
Clinical Trial
ID

ClinicalTrials.gov
CTIS

Summary of
Clinical Trial
Summary
Results
Summary Results in Plain Language
Back to the Top Page

Contact Information

For questions regarding disclosure of clinical trial information, please email us: